Reported covered position: Chief of Staff, Rep. Melissa Bean (2005-2009); Chief of Staff, Rep. Chris Bell (2003-2005)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: TIBER CREEK HEALTH STRATEGIES, INC.
S. 4750 Restore Protections for Dialysis Patients Act.
Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; S. 2543 - The Prescription Drug Price Reduction Act; H.R. 3 - Lower Drug Costs Now Act of 2019; Part B home infusion; H.R. 133/PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2026 · third_quarter · Q3
Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2026 · second_quarter · Q2
Source: Senate LDA
CARE for All Kidneys Act of 2021
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: TIBER CREEK HEALTH STRATEGIES, INC.
H.R. 3893 - Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021.
A bill to require a study on the national security implications of the People's Republic of China's efforts to create an official digital currency.
Client: AMGEN, INC. · Firm: TIBER CREEK HEALTH STRATEGIES, INC.
Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; S. 2543 - The Prescription Drug Price Reduction Act; H.R. 3 - Lower Drug Costs Now Act of 2019; Part B home infusion; H.R. 133/PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN, INC. · Firm: TIBER CREEK HEALTH STRATEGIES, INC.
Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; S. 2543 - The Prescription Drug Price Reduction Act; H.R. 3 - Lower Drug Costs Now Act of 2019; Part B home infusion; H.R. 133/PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2026 · first_quarter · Q1
Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2025 · fourth_quarter · Q4
Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2025 · third_quarter · Q3
Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2025 · second_quarter · Q2
Issues related to Medicare reimbursement; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2025 · first_quarter · Q1
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2024 · fourth_quarter · Q4
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2024 · third_quarter · Q3
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2024 · second_quarter · Q2
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2024 · first_quarter · Q1
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2023 · fourth_quarter · Q4
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2023 · third_quarter · Q3
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2023 · second_quarter · Q2
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2023 · first_quarter · Q1
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2022 · fourth_quarter · Q4
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2022 · third_quarter · Q3
S. 4750 Restore Protections for Dialysis Patients Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2022 · second_quarter · Q2
Establishing dialysis facilities as an originating site for the purpose of allowing patients to access telehealth services; Issues related generally to expanding telehealth services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2022 · first_quarter · Q1
Establishing dialysis facilities as an originating site for the purpose of allowing patients to access telehealth services; Issues related generally to expanding telehealth services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2021 · third_quarter · Q3
H.R. 3893 - Coordination, Accountability, Research, and Equity for All Kidneys Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN, INC. via TIBER CREEK HEALTH STRATEGIES, INC.
2021 · first_quarter · Q1
Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; S. 2543 - The Prescription Drug Price Reduction Act; H.R. 3 - Lower Drug Costs Now Act of 2019; Part B home infusion; H.R. 133/PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via TIBER CREEK HEALTH STRATEGIES, INC.
2020 · fourth_quarter · RA
Issues related to end-stage renal disease.